CXCL8



CXCL8

A1AA1V2VV2L3LL3P4PP4R5RR5S6SS6A7AA7K8KK8E9EE9L10LL10R11RR11C12CC12Q13QQ13C14CC14I15II15K16KK16T17TT17Y18YY18S19SS19K20KK20P21PP21F22FF22H23HH23P24PP24K25KK25F26FF26I27II27K28KK28E29EE29L30LL30R31RR31V32VV32I33II33E34EE34S35SS35G36GG36P37PP37H38HH38C39CC39A40AA40N41NN41T42TT42E43EE43I44II44I45II45V46VV46K47KK47... and 30 more residue(s)...... and 30 more residue(s)

SMILES None
InChIKey None
Sequence AVLPRSAKELRCQCIKTYSKPFHPKFIKELRVIESGPHCANTEIIVKLSDGRELCLDPKENWVQRVVEKFLKRAENS

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections

Ligand site mutations CXCR1 CXCR2

No bioactivity data available.

CXCL8

A1AA1V2VV2L3LL3P4PP4R5RR5S6SS6A7AA7K8KK8E9EE9L10LL10R11RR11C12CC12Q13QQ13C14CC14I15II15K16KK16T17TT17Y18YY18S19SS19K20KK20P21PP21F22FF22H23HH23P24PP24K25KK25F26FF26I27II27K28KK28E29EE29L30LL30R31RR31V32VV32I33II33E34EE34S35SS35G36GG36P37PP37H38HH38C39CC39A40AA40N41NN41T42TT42E43EE43I44II44I45II45V46VV46K47KK47... and 30 more residue(s)...... and 30 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections

Ligand site mutations CXCR1 CXCR2

Compound is not listed as a drug.